![]() |
| Perivascular fibroblasts observed in the study Image Credit: Courtesy of the researcher / University of Notre Dame |
Glioblastoma is one of the most treatment-resistant cancers, with those diagnosed surviving for less than two years.
In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how aggressive, primary brain cancer is able to resist immunotherapy.
“A decade ago, we didn’t even know perivascular fibroblasts existed within the brain, and not just in the lining of the skull,” said Meenal Datta, assistant professor of aerospace and mechanical engineering at Notre Dame and senior author on the study. “My lab’s expertise is examining tumors from an engineering and systems-based approach and looking at the novel mechanical features in rare cancers that may have been understudied or overlooked.”
Using standard bioinformatics and newer AI-based approaches, Datta’s TIME Lab began analyzing different genes expressed in the tumor microenvironment related to the extracellular matrix — or the scaffolding cells create to support future cell adhesion, migration, proliferation and differentiation — and other various cell types. What they found was a surprising, fairly new cell type: perivascular fibroblasts. These fibroblasts are typically found in the blood vessels of a healthy brain and deposit collagen to maintain the structural integrity and functionality of brain vessels.


.jpg)


.jpg)


.jpg)
.jpg)


.jpg)
